Long-Term High Flow Nasal Cannula Therapy in Primary and Secondary Bronchiectasis.

Francesca Simioli Giuseppe FiorentinoRosa CauteruccioAntonietta CoppolaPasquale ImitazioneAntonella MarottaValentina Di SpiritoAnna Annunziata

Published in: Healthcare (Basel, Switzerland) (2023)

HFNC is a well-tolerated add-on therapy for adult bronchiectasis. Dyspnea improved after 2 months and further after 2 years. The exacerbation rate decreased during the 2 years follow-up. No significant difference was observed in lung function.

Keyphrases

lung function
cystic fibrosis
chronic obstructive pulmonary disease
air pollution
respiratory failure
extracorporeal membrane oxygenation
bone marrow
intensive care unit
positive airway pressure
palliative care
advanced cancer